Billatos, Ehab http://orcid.org/0000-0002-6645-1758
,
Duan, Fenghai
Moses, Elizabeth
Marques, Helga
Mahon, Irene
Dymond, Lindsey
Apgar, Charles
Aberle, Denise
Washko, George
Spira, Avrum
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-11-2-0161)
National Cancer Institute (U01CA196408)
Janssen Research and Development
Article History
Received: 22 June 2018
Accepted: 26 February 2019
First Online: 7 March 2019
Ethics approval and consent to participate
: This study was approved by the Human Research Protection Office (HRPO) for the Department of Defense, and the individual site IRBs for every participating site. All subjects were approached for written informed consent to participate in the study in accordance with IRB regulations.
: Not Applicable
: E.B., F.D., E.M., H.M., I.M., L.D., C.A., and D.A. have no competing interests. G.W. is a consultant for Boehringer Ingelheim and Janssen Pharmaceuticals. G.W. is founder and co-owner of Quantitative Imaging Solutions. A.S. is an employee of Johnson and Johnson.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.